XML 50 R40.htm IDEA: XBRL DOCUMENT
v3.5.0.2

Revenue Recognition - Additional Information (Detail) - USD ($) |  |  | 3 Months Ended | 6 Months Ended
--- | --- | --- | --- | ---
Sep. 03, 2014 | Jan. 30, 2014 | Mar. 31, 2014 | Jun. 30, 2016
Revenue Recognition, Multiple-deliverable Arrangements [Line Items] |  |  |  |
Non-refundable up-front payment |  |  |  | $ 2,000,000
Payment to be received upon signing of agreement |  |  |  | 125,675
Revenue recognized |  |  |  | 2,115,000
Revenue recognized under revenue recognition, up front payment |  |  | $ 2,000,000 |
Clinical Development |  |  |  |
Revenue Recognition, Multiple-deliverable Arrangements [Line Items] |  |  |  |
Milestone Payment |  |  |  | 60,000,000
Potential milestone payments to be received |  |  |  | 60,000,000
Initial Commercial Sales |  |  |  |
Revenue Recognition, Multiple-deliverable Arrangements [Line Items] |  |  |  |
Potential milestone payments to be received |  |  |  | 100,000,000
BioMarin Pharmaceutical, Inc. | Asset Purchase Agreement |  |  |  |
Revenue Recognition, Multiple-deliverable Arrangements [Line Items] |  |  |  |
Upfront payment received under purchase agreement |  | $ 2,000,000 |  |
Potential milestone payments to be received |  |  |  | 160,000,000
Provision for refund |  |  |  | $ 0
BioMarin Pharmaceutical, Inc. | Clinical Development | Asset Purchase Agreement |  |  |  |
Revenue Recognition, Multiple-deliverable Arrangements [Line Items] |  |  |  |
Percentage relate to clinical development from Milestone payment |  |  |  | 37.00%
BioMarin Pharmaceutical, Inc. | Initial Commercial Sales | Asset Purchase Agreement |  |  |  |
Revenue Recognition, Multiple-deliverable Arrangements [Line Items] |  |  |  |
Percentage relate to clinical development from Milestone payment |  |  |  | 63.00%
BioMarin Pharmaceutical, Inc. | Technology Transfer Payments | Asset Purchase Agreement |  |  |  |
Revenue Recognition, Multiple-deliverable Arrangements [Line Items] |  |  |  |
Milestone Payment | $ 125,675 |  |  |

X
- Definition Amount To Be Received Upon Completion Of Transfer + References No definition available. + Details
Name: | rgen_AmountToBeReceivedUponCompletionOfTransfer
Namespace Prefix: | rgen_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Non Contingent Consideration Being Recognized As Revenue Over Estimated Period Of Performance + References No definition available. + Details
Name: | rgen_NonContingentConsiderationBeingRecognizedAsRevenueOverEstimatedPeriodOfPerformance
Namespace Prefix: | rgen_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Nonrefundable Upfront Cash Payment Under Collaborations Agreement + References No definition available. + Details
Name: | rgen_NonrefundableUpfrontCashPaymentUnderCollaborationsAgreement
Namespace Prefix: | rgen_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Percentage Of Future Milestone Payments + References No definition available. + Details
Name: | rgen_PercentageOfFutureMilestonePayments
Namespace Prefix: | rgen_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Potential Additional Milestone Payments Associated With Potential Regulatory Approvals + References No definition available. + Details
Name: | rgen_PotentialAdditionalMilestonePaymentsAssociatedWithPotentialRegulatoryApprovals
Namespace Prefix: | rgen_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Provision For Wholesale Refunds + References No definition available. + Details
Name: | rgen_ProvisionForWholesaleRefunds
Namespace Prefix: | rgen_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of deferred revenue recognized for transactions arising during the current reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an Entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 13.A.4(a).Q1) -URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 13.A.3) -URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780 + Details
Name: | us-gaap_DeferredRevenueAdditions
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of revenue recognized that was previously reported as deferred or unearned revenue. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 13.A.4(a).Q1 Response)) -URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780 + Details
Name: | us-gaap_DeferredRevenueRevenueRecognized1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of consideration recognized during the period for the milestone or milestones. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 28 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=68058744&loc=SL6892177-166501 + Details
Name: | us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_RevenueRecognitionMultipleDeliverableArrangementsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=rgen_ClinicalResearchMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=rgen_FirstCommercialSaleMilestoneEventsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MajorCustomersAxis=rgen_BiomarinPharmaceuticalIncorporatedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DeferredRevenueArrangementTypeAxis=rgen_AssetPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=rgen_TechnologyTransferPaymentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |